Lifeist Wellness Inc.’s NXTTF LFST M net revenue decreased 15% to CA$4.1 million ($3.19 million) in Q2 2022 compared to CA$4.9 million in Q2 2021.
Q2 2022 Financial Highlights
-
Gross margin was CA$700,000 (16% of net revenue) in Q2 2022 compared to CA$400,000 (7%) in Q2 2021. The increase in gross profit in Q2 2022 represents the company’s fourth highest quarterly gross profit, despite the loss of two months of sales by Australian Vaporizers.
-
Adjusted EBITDA loss was CA$4.5 million in Q2 2022 compared to a loss of CA$5.4 million in Q2 2021.
-
Net loss was CA$3.9 million in Q2 2022 compared to CA$6.4 million in Q2 2021, due to improved gross margins, lower operating expenses, and a gain on sale of CA$900,000 in the quarter from the disposition of the company’s subsidiary Findify AB on May 25, 2022.
“The Australian floods dampened what was otherwise a solid quarter for Lifeist,” stated Meni Morim, CEO of Lifeist. “While it’s been a difficult period for the broader cannabis industry, we’re generating measurable success and establishing a path to profitability for our recreational cannabis distribution platform. Meanwhile, while encountering industry-wide supply chain disruption challenges, our nutraceuticals business was still able to achieve the correct acquisition and retention metrics to enable profitable growth and I expect this execution in the coming quarters. As for Australian Vaporizers, following the effects of the devastating flood, the business re-opened its doors in May and generated sales operating metrics consistent with pre-shutdown levels, and that normally positive performance has continued into fiscal Q3 2022.”
Cash and cash equivalents were CA$6.6 million as of May 31, 2022, compared to CA$12.6 million as of November 30, 2021.
Photo by Mackenzie Marco on Unsplash
Related News
Lifeist Sells Non-Core Swedish Subsidiary Findify For CA$4.45M To Maropost
Lifeist Wellness Reduces Net Los By 37.83% To CA$3.6M In Q1 2022
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.